Crinetics Pharmaceuticals held special shareholder meeting on merger proposal vote

• Crinetics held a special shareholder meeting on Aug. 28, 2026 to vote on a merger agreement with Vertex.
• Shareholders adopted the merger agreement on a non-binding advisory basis; the transaction is expected to close around Sept. 1, 2026.
• An advisory vote on merger-related executive compensation failed to pass.
• A proposed meeting adjournment resolution was not put to a vote because support for the merger agreement was sufficient.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-034857), on August 28, 2026, and is solely responsible for the information contained therein.